Sitagliptin is a triazolopyrazine compound that acts as a hypoglycemic agent. It functions as a serine proteinase inhibitor and an inhibitor of dipeptidyl-peptidase IV (EC 3.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 486460-32-6
Sitagliptin phosphate hydrate
pharmaceutical raw material
Sitagliptin phosphate
pharmaceutical raw material
Sitagliptin monohydrochloride monohydrate
pharmaceutical raw material
Sitagliptin tartrate hemihydrate
pharmaceutical raw material
Vinburnine
pharmaceutical raw material
Icariin
pharmaceutical raw material
Globulol
pharmaceutical raw material
Gentisic acid
pharmaceutical raw material
(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one
MFFMDFFZMYYVKS-SECBINFHSA-N
C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)C[C@@H](CC3=CC(=C(C=C3F)F)F)N